Rhino-orbital mucormycosis with cutaneous involvement in an HBV-positive patient: a case report and review of the literature
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20251518Keywords:
Cutaneous, Hepatitis B, Immunocompetent, Mucormycosis, Rhino-cerebralAbstract
Mucormycosis is a rare fungal angioinvasive disease characterized by infarction and tissue necrosis. It is an opportunistic infection mainly affecting patients with impaired immunity, as seen in patients with diabetes mellitus with or without ketoacidosis, injudicious use of steroid therapy, hematological malignancy, bone marrow transplant, chemotherapy, neutropenia, as well with deferoxamine therapy. The various clinical variants of mucormycosis include rhino-orbitocerebral, pulmonary, cutaneous, and disseminated forms, among which the rhino-orbital-cerebral type is the most common. A notable rise in mucormycosis cases has been observed among patients with history of COVID-19. Contributing factors may consist of thromboembolic events linked to substandard oxygen administration practices, altered cardiopulmonary dynamics, and the injudicious use of steroids and antibiotics during COVID-19 treatment. Early diagnosis and urgent surgical and medical intervention form the cornerstone of a successful outcome. In our case report, we present a 55-year-old hepatitis B-positive patient with rhino-orbital mucormycosis with cutaneous involvement. This report emphasizes on the challenges faced in the management of patients with Hepatitis B-associated mucormycosis. We report a rare rhino-orbital mucormycosis (ROCM) case with cutaneous involvement in a patient with active Hepatitis B virus (HBV) infection and no other risk factors. The study emphasizes on early surgical and medical intervention and adequate control of comorbidity contributing to impaired immunity for a favorable prognosis.
Metrics
References
Sharma A, Goel A. Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic. Folia Microbiologica. 2022;67(3):363-87. DOI: https://doi.org/10.1007/s12223-021-00934-5
Fleckner RA, Goldstein JH. Mucormycosis. Br J Ophthalmol. 1969;53(8):542. DOI: https://doi.org/10.1136/bjo.53.8.542
Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SC, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium. Lancet Infect Dis. 2019;19(12):405-21. DOI: https://doi.org/10.1016/S1473-3099(19)30312-3
Prabhu S, Alqahtani M, Al Shehabi M. A fatal case of rhinocerebral mucormycosis of the jaw after dental extractions and review of literature. J Infect Pub Heal. 2018;11(3):301-3. DOI: https://doi.org/10.1016/j.jiph.2017.09.026
Aras MH, Kara MI, Erkiliç S, Ay S. Mandibular mucormycosis in immunocompromised patients: report of 2 cases and review of the literature. J Oral maxillofac Surg. 2012;70(6):1362-8. DOI: https://doi.org/10.1016/j.joms.2011.05.012
Mattingly JK, Ramakrishnan VR. Rhinocerebral mucormycosis of the optic nerve. Otolaryngol Head Neck Surg. 2016;155(5):888-9. DOI: https://doi.org/10.1177/0194599816658024
Steinbrink JM, Miceli MH. Mucormycosis. Infectious Dis Clin. 2021;35(2):435-52. DOI: https://doi.org/10.1016/j.idc.2021.03.009
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634-53. DOI: https://doi.org/10.1086/432579
Patel A, Kaur H, Xess I, Michael JS, Savio J, Rudramurthy S, et al. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Inf. 2020;26(7):944-9. DOI: https://doi.org/10.1016/j.cmi.2019.11.021
Shamanna K, Fathima A, Sowjanya S. Rhino-orbito-cerebral mucormycosis: our experience. Headache. 2019;15:75.
Gavito-Higuera J, Mullins CB, Ramos-Duran L, Sandoval H, Akle N, Figueroa R. Sinonasal fungal infections and complications: a pictorial review. J Clin Imag Sci. 2016;6:410. DOI: https://doi.org/10.4103/2156-7514.184010
Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DC, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol and Infect. 2019;25(1):26-34. DOI: https://doi.org/10.1016/j.cmi.2018.07.011
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020;395(10229):1033-4. DOI: https://doi.org/10.1016/S0140-6736(20)30628-0
Barros N, Rosenblatt RE, Phipps MM, Fomin V, Mansour MK. Invasive fungal infections in liver diseases. Hepatol Commun. 2023;7(9):216. DOI: https://doi.org/10.1097/HC9.0000000000000216
Wu YP, Li FC, Ma HY, Yang XY, Zuo J, Tian YX, et al. Characteristics and risk factors for invasive fungal infection in hospitalized patients with acute-on-chronic hepatitis B liver failure: a retrospective cohort study from 2010 to 2023. Front Microbiol. 2024;15:1391814. DOI: https://doi.org/10.3389/fmicb.2024.1391814
Wang Y, Li XY, Wu LL, Zheng XY, Deng Y, Li MJ, et al. Dynamic prediction of liver cirrhosis risk in chronic hepatitis B patients using longitudinal clinical data. Euro J Gastroenterol Hepatol. 2020;32(1):120-6. DOI: https://doi.org/10.1097/MEG.0000000000001592
Gao Y, You M, Fu J, Tian M, Zhong X, Du C, et al. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B. J Hepatol. 2022;76(1):148-59. DOI: https://doi.org/10.1016/j.jhep.2021.08.029
Lin SY, Lu PL, Tsai KB, Lin CY, Lin WR, Chen TC, et al. A mucormycosis case in a cirrhotic patient successfully treated with posaconazole and review of published literature. Mycopatholog. 2012;174:499-504.
Abbas Z, Jafri W, Rasool S, Abid S, Hameed I. Mucormycosis in patients with complicated cirrhosis. Singapore Med J. 2007;48(1):69.
Ataseven H, Gültuna S, Köklü S, Uysal S, Başar Ö, Şaşmaz N. Fatal rhinocerebral mucormycosis under the shade of hepatic encephalopathy. Ann Hepatol. 2010;9(4):462-4. DOI: https://doi.org/10.1016/S1665-2681(19)31624-2
Chaudhry A, Hirano SA, Hayes TJ, Torosky C. Fatal rhino-orbito-cerebral mucormycosis in a patient with liver disease. J Am Acad Dermatol. 2011;65(1):241-3. DOI: https://doi.org/10.1016/j.jaad.2010.01.002
Georgopoulou S, Kounougeri E, Katsenos C, Rizos M, Michalopoulos A. Rhinocerebral mucormycosis in a patient with cirrhosis and chronic renal failure. Hepato-Gastroenterol. 2003;50(51):843-5.
Hibbett DS, Binder M, Bischoff JF, Blackwell M, Cannon PF, Eriksson OE, et al. A higher-level phylogenetic classification of the Fungi. Mycological Res. 2007;111(5):509-47. DOI: https://doi.org/10.1016/j.mycres.2007.03.004
Hofman P, Gari-Toussaint M, De Bievre C, Michiels JF, d'Horpock FA, Loubiere R. Rhino-orbito-cerebral mucormycosis caused by Rhizopus oryzae. A typical case in a cirrhotic patient. InAnnales de Pathologie 1993;13(3):80-3.
Kikuchi H, Kinoshita Y, Arima K, Doh-ura K, Hisatomi Y, Hashimoto T, et al. An autopsy case of rhino-orbito-cerebral mucormycosis associated with multiple cranial nerve palsy and subsequent subarachnoid hemorrhage. Rinsho Shinkeigaku Clin Neurol. 1998;38(3):252-5.
Lin SY, Lu PL, Tsai KB, Lin CY, Lin WR, Chen TC, et al. A mucormycosis case in a cirrhotic patient successfully treated with posaconazole and review of published literature. Mycopathologia. 2012;174:499-504. DOI: https://doi.org/10.1007/s11046-012-9561-8
Pellicelli AM, D'Ambrosio C, Villani R, Cerasari G, Ialongo P, Cortese A, et al. Liver cirrhosis and rhino-orbital mucormycosis, a possible but rare association: description of a clinical case and literature review. Brazilian J Infect Dis. 2009;13:314-6. DOI: https://doi.org/10.1590/S1413-86702009000400015
Raizman NM, Parisien M, Grafe MW, Gordon RJ, Rosenwasser MP. Mucormycosis of the upper extremity in a patient with alcoholic encephalopathy. The J Hand Surg. 2007;32(3):384-8. DOI: https://doi.org/10.1016/j.jhsa.2007.01.009
Naqvi HA, Nadeem Yousaf M, Chaudhary FS, Mills L. Gastric mucormycosis: An infection of fungal invasion into the gastric mucosa in immunocompromised patients. Case reports in gastrointestinal medicine. 2020;2(1):8876125. DOI: https://doi.org/10.1155/2020/8876125
Wollstein R, Palekar A. Mucormycosis infection following intravenous access in the forearm. Canadian J Plas Surg. 2010;18(2):30-2. DOI: https://doi.org/10.1177/229255031001800205
Elsiesy H, Saad M, Shorman M, Amr S, Abaalkhail F, Hashim A, et al. Invasive mucormycosis in a patient with liver cirrhosis: case report and review of the literature. Hepatitis Monthly. 2013;13(8):858 DOI: https://doi.org/10.5812/hepatmon.10858
Menezes S, Kumar JS, Rudra OS, Nagral A. Cutaneous mucormycosis: an unusual cause of decompensation in a patient with ethanol-related cirrhosis with COVID-19 exposure. BMJ Case Reports CP. 2022;15(2):247399. DOI: https://doi.org/10.1136/bcr-2021-247399
Sabobeh T, Mushtaq K, Elsotouhy A, Ammar AA, Rashid S. Invasive rhinocerebral mucormycosis in a patient with liver cirrhosis leading to fatal massive stroke. Medical Mycol Case Rep. 2018;22:69-73. DOI: https://doi.org/10.1016/j.mmcr.2018.09.006
Rodriguez DA, Virgen GO, Ackerman RC. A tip from the nose: rhinocerebral mucormycosis in a patient with alcoholic liver cirrhosis and cocaine abuse, an uncommon association. Case Rep. 2017;2:45-7. DOI: https://doi.org/10.1136/bcr-2017-220730
Persichino JG, Can AD, Van TT, Matthews MN, Filler SG. Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis. Med Mycol Case Rep. 2018;21:12-5. DOI: https://doi.org/10.1016/j.mmcr.2018.03.004
Vijapur MM, Ulasandra SV, Kattimani V, Yelamali TA, Ram B, Kumar VV. Rhino maxillary mucormycosis in a HBsAg positive patient with OSMF. J Adv Medical Dental Sci Res. 2021;9(11):31-4.
Khatun MA, Karim S, Islam A. Mucormycosis induced liver abscess in a child with Acute lymphoblastic leukemia: A rare case report. Cancer J Bangladesh. 2022;3(2):77-9.
Rihawi A, Salem A, Mousa AA, Soliman M, Patel S, Uppalapu S. Watch for the unusual: a rare case of nasal mucormycosis infection presenting as a septic shock in a patient with end-stage renal disease and liver cirrhosis. Chest. 2022;162(4):510-1. DOI: https://doi.org/10.1016/j.chest.2022.08.395
Ansari N, Paul S, Ahmed S, Chakrabortty R, Rahman A. Pulmonary Mucormycosis in a Patient with Decompensated Cirrhosis of the Liver Successfully Treated with Oral Posaconazole: a case report. Avaialble at: https://www.authorea.com. Accessed on 23 November 2024. DOI: https://doi.org/10.22541/au.172523120.04467110/v1
Ji R. Mucormycosis mimicking portal hypertensive haemorrhage as a complication of alcoholic liver cirrhosis: a case report. BMC Infectious Dis. 2024;24(1):136. DOI: https://doi.org/10.1186/s12879-023-08220-0
Downloads
Published
How to Cite
Issue
Section
